Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Abstract

Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.

J Wess, D Gdula and M R Brann
Molecular Pharmacology February 1992, 41 (2) 369-374;
J Wess
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D Gdula
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M R Brann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 41 no. 2 369-374
PubMed 
1538713

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online February 1, 1992.


Author Information

  1. J Wess,
  2. D Gdula and
  3. M R Brann
  1. National Institute of Neurological Disorders and Stroke, Laboratory of Molecular Biology, Bethesda, Maryland 20892.

    Statistics from Altmetric.com

    Article usage

    Article usage: March 2000 to May 2023

    AbstractFullPdf
    Mar 2000100
    Nov 2000100
    May 2001300
    Jun 2001100
    Aug 2001100
    Apr 2002100
    May 2002100
    Oct 2002400
    Nov 2002300
    Feb 2003100
    Mar 2003100
    Apr 2003100
    May 2003100
    Jun 2003100
    Jul 2003600
    Aug 2003900
    Sep 20031000
    Oct 20031400
    Nov 20031000
    Dec 20031000
    Jan 20041100
    Feb 2004800
    Mar 2004400
    Apr 2004500
    May 2004500
    Jun 2004900
    Jul 2004800
    Aug 2004400
    Sep 2004600
    Oct 2004900
    Nov 2004400
    Dec 2004800
    Jan 20051400
    Feb 2005700
    Mar 20051100
    Apr 2005600
    May 2005500
    Jun 2005300
    Aug 2005001
    Sep 2005001
    Oct 2005200
    Nov 2005204
    Dec 2005202
    Jan 2006401
    Feb 2006500
    Mar 2006303
    Apr 2006200
    May 2006413
    Jun 2006400
    Jul 2006101
    Aug 2006200
    Sep 2006203
    Oct 2006103
    Nov 2006202
    Dec 2006100
    Jan 2007200
    Feb 2007100
    Mar 2007403
    Apr 2007503
    May 2007200
    Jun 2007002
    Jul 2007504
    Aug 2007304
    Sep 2007201
    Oct 2007203
    Nov 2007001
    Dec 2007102
    Jan 2008100
    Feb 2008001
    Mar 2008202
    Apr 2008205
    May 2008300
    Jun 2008303
    Jul 2008001
    Aug 2008101
    Sep 2008201
    Nov 2008201
    Dec 2008100
    Jan 2009201
    Feb 2009100
    Mar 2009100
    Apr 2009101
    May 2009100
    Jul 2009001
    Sep 2009401
    Oct 2009500
    Nov 2009500
    Dec 2009600
    Feb 2010300
    Mar 2010502
    Apr 2010500
    May 2010302
    Jun 2010100
    Aug 2010200
    Sep 2010100
    Dec 2010100
    Jan 2011801
    Feb 2011001
    Mar 2011401
    Apr 2011403
    May 2011100
    Jul 2011500
    Aug 2011200
    Sep 2011400
    Nov 2011500
    Dec 2011100
    Jan 2012100
    Feb 2012201
    Mar 2012200
    Apr 2012100
    May 2012200
    Jun 2012101
    Jul 2012400
    Aug 2012100
    Sep 2012502
    Oct 2012200
    Nov 2012102
    Dec 2012103
    Jan 2013100
    Feb 2013300
    Apr 2013600
    May 2013400
    Jun 2013103
    Jul 2013201
    Aug 2013100
    Sep 2013200
    Oct 2013401
    Nov 2013300
    Dec 2013001
    Jan 2014600
    Feb 2014100
    Mar 2014001
    Apr 2014001
    May 2014101
    Jun 2014200
    Jul 2014200
    Sep 2014201
    Oct 2014300
    Nov 2014300
    Dec 20141501
    Jan 2015100
    Mar 2015300
    May 2015400
    Jun 2015700
    Jul 2015500
    Aug 2015300
    Nov 2015301
    Dec 2015401
    Jan 2016800
    Feb 2016200
    Mar 20161102
    Apr 2016303
    May 2016101
    Jun 2016100
    Jul 2016201
    Aug 2016200
    Sep 2016702
    Oct 2016402
    Nov 2016200
    Dec 2016900
    Jan 20171201
    Feb 2017800
    Mar 2017703
    Apr 20171602
    May 2017301
    Jun 2017301
    Jul 2017200
    Aug 2017600
    Sep 2017500
    Oct 20171000
    Nov 2017800
    Dec 2017700
    Jan 2018800
    Feb 2018500
    Mar 2018500
    Apr 20181402
    May 20181100
    Jun 2018800
    Jul 2018100
    Aug 2018702
    Sep 2018301
    Oct 2018901
    Nov 2018500
    Dec 2018600
    Jan 2019902
    Feb 2019400
    Mar 20191400
    Apr 2019700
    May 2019200
    Jun 20191006
    Jul 2019402
    Aug 2019400
    Sep 20191300
    Oct 20192202
    Nov 20191001
    Dec 20191301
    Jan 2020701
    Feb 2020500
    Mar 2020300
    Apr 2020200
    May 2020300
    Jun 2020200
    Jul 2020400
    Aug 2020400
    Sep 2020600
    Oct 2020100
    Nov 2020700
    Dec 2020700
    Jan 20211300
    Feb 20211401
    Mar 2021901
    Apr 2021900
    May 2021600
    Jun 2021400
    Jul 2021500
    Aug 2021600
    Sep 2021700
    Oct 2021800
    Nov 20211700
    Dec 2021300
    Jan 20221501
    Feb 2022400
    Mar 2022501
    Apr 2022801
    May 2022501
    Jun 20221602
    Jul 20221200
    Aug 2022300
    Sep 20221300
    Oct 2022900
    Nov 20221700
    Dec 2022700
    Jan 2023700
    Feb 2023801
    Mar 20231500
    Apr 20231200
    May 2023700

    PreviousNext
    Back to top

    In this issue

    Molecular Pharmacology
    Vol. 41, Issue 2
    1 Feb 1992
    • Table of Contents
    • Table of Contents (PDF)
    • Index by author
    • Back Matter (PDF)
    • Editorial Board (PDF)
    • Front Matter (PDF)
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Molecular Pharmacology article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
    (Your Name) has forwarded a page to you from Molecular Pharmacology
    (Your Name) thought you would be interested in this article in Molecular Pharmacology.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Abstract

    Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.

    J Wess, D Gdula and M R Brann
    Molecular Pharmacology February 1, 1992, 41 (2) 369-374;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Abstract

    Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.

    J Wess, D Gdula and M R Brann
    Molecular Pharmacology February 1, 1992, 41 (2) 369-374;
    Reddit logo Twitter logo Facebook logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About Molecular Pharmacology
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0111 (Online)

    Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics